Showing results (801-810 of 1,007) with videos related to

Sort By:
Pageof 101
Thrombosis Journal|November 23, 2021
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort studyJia Peng, Ming-Ming Liu, Hui-Hui Liu, et al.
Thrombosis Journal|March 13, 2021
ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational studyHironori Matsumoto, Jun Takeba, Kensuke Umakoshi, et al.
Thrombosis Journal|June 5, 2008
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapyAjay Srivastava, Michael Hudson, Ihab Hamoud, et al.
Thrombosis Journal|July 16, 2019
Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experienceAbu-Sayeef Mirza, Seongseok Yun, Najla Al Ali, et al.
Thrombosis Journal|September 1, 2012
Effects of computer-assisted oral anticoagulant therapyRune Skovgaard Rasmussen, Pernille Corell, Poul Madsen, et al.
Thrombosis Journal|October 19, 2012
Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosisMila Menozzi, Andrea Rubboli, Antonio Manari, et al.
Thrombosis Journal|August 29, 2012
Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterolXiao Sun, Man Zhang, Akimasa Sanagawa, et al.
Thrombosis Journal|August 23, 2012
Platelet-dependent thrombography gives a distinct pattern of in vitro thrombin generation after surgery with cardio-pulmonary bypass: potential implicationsRose Said, Véronique Regnault, Marie Hacquard, et al.
Thrombosis Journal|January 11, 2005
The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapyAndrew J Bond, Frank J Molnar, Marilyn Li, et al.
Thrombosis Journal|November 9, 2004
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhageAnita Aggarwal, Vera Malkovska, Joseph P Catlett, et al.
Pageof 101